Hain Celestial Earnings Call Signals Early Turnaround

The Hain Celestial ((HAIN)) has held its Q3 earnings call. Read on for the main highlights of the call.

The Hain Celestial’s latest earnings call struck a cautiously hopeful tone as management framed the quarter as a financial inflection point despite weaker year-over-year results. Executives highlighted stronger cash generation, deleveraging and margin progress as signs the reshaped North American portfolio is gaining traction, but emphasized that international softness, category headwinds and strategic uncertainty still weigh on the outlook.

Robust Cash Generation and Rapid Debt Reduction

Hain Celestial generated $35 million of free cash flow in the quarter, a sharp turnaround from a $2 million outflow a year earlier that underscores tighter cash discipline and improved working capital. Management used this cash to pare total debt by $155 million, bringing net debt down to $505 million, a $145 million reduction year-to-date and a $272 million cut over the last 11 quarters.

North America Snacks Sale Reshapes Portfolio Economics

The company closed the sale of its North America snacks business on February 27, a move that materially bolstered cash generation and is central to its portfolio simplification strategy. Management said roughly 70% of stranded cost actions tied to this divestiture are already implemented and highlighted that the transaction should be accretive to both gross margin and EBITDA for the remaining business.

Sequential Margin Gains and Stronger North America Profile

Adjusted gross margin improved sequentially by about 150 basis points to 21%, even though it was still roughly 90 basis points below last year due to inflation and mix pressure. North America stood out with a 100 basis point year-over-year improvement to 23.4% adjusted gross margin, and management noted that excluding snacks, the region would have delivered about 30% gross margin and a 16.4% adjusted EBITDA margin.

Innovation Pipeline Fuels Category Pockets of Growth

Innovation is becoming a larger growth engine, with renewal rates above 12% of net sales, more than 2.5 points higher than a year ago and signaling a healthier product pipeline. The company called out high-teen dollar sales growth for Greek Gods yogurt, high-single-digit gains in wellness teas and mid- to high-single-digit growth in Earth’s Best finger foods, supported by launches like high-protein yogurt, new gut and throat wellness teas and a refreshed Hartley’s lineup.

Improved Inventory Discipline and Working Capital Efficiency

Operationally, Hain Celestial is tightening its balance sheet, reducing days inventory outstanding to 73 from 79 a year ago and 75 last quarter, which boosts cash conversion. Better accounts receivable collections and modest capital expenditures of $4 million in the quarter add to working capital gains, giving the company more flexibility to fund restructuring and growth initiatives without stretching its balance sheet.

Restructuring Nearing Completion with Targeted Savings

The transformation program is well advanced, with $108 million of charges taken against an expected $115 million to $125 million and management reaffirming total benefits of $130 million to $150 million by fiscal 2027. Stranded costs are now projected at the high end of $20 million to $25 million, with about half of the remaining reductions scheduled before the end of the second quarter of fiscal 2027 and the balance exiting by year-end.

Solid Liquidity and Interest Rate Protection

On liquidity, the company reported $44 million of cash and $196 million of available capacity on its revolving credit facility, giving it room to maneuver as it navigates its strategic review and upcoming maturities. Net leverage sits at 4.3 times against a covenant of 5.5 times, and Hain Celestial has hedged more than 70% of its loan facility at a fixed 7.1% rate, providing partial protection from further interest rate volatility.

Organic Sales Under Pressure as Volume Declines

Despite the financial housekeeping progress, top-line performance remained soft with total organic net sales down 6% year-over-year, driven by an 8% decline internationally and a 3% drop in North America excluding the divested snacks business. The company noted an 11-point headwind from volume and mix that was only partially offset by 5 points of price, highlighting the limitations of pricing power in offsetting demand softness.

Squeezed Profitability with Lower EBITDA and Net Results

Profitability also deteriorated versus last year, as adjusted EBITDA fell to $26 million from $34 million, a roughly 23.5% decline that reflects weaker volumes and cost inflation despite sequential margin gains. The adjusted EBITDA margin came in at 7.8%, up from 6.3% last quarter, but the company swung to an adjusted net loss of $1 million compared with an adjusted net income of $6 million in the prior-year period.

International Segment Hit by Cost and Competitive Pressures

The international segment remained a weak spot, with organic net sales down 8% and adjusted gross margin compressing by 270 basis points to 18.5% amid cost inflation and unfavorable mix. Adjusted EBITDA in the region fell 12% to $20 million, representing 11.7% of net sales, as private label competition intensified and volume softness eroded operating leverage.

Baby & Kids Category Faces Structural Headwinds

The Baby & Kids business saw one of the steepest declines, with organic net sales dropping 14% year-over-year as industry-wide weakness in wet baby food and purees in the U.K. and softness in formula and purees in North America weighed on results. Growth in finger foods and cereal offered some relief but was not enough to offset the broader category downturn, signaling a tougher demand environment in this core franchise.

Inflation and Volume Mix Still Dragging Margins

Management acknowledged that adjusted gross margin’s roughly 90 basis point year-over-year decline reflects ongoing cost inflation and unfavorable volume mix despite productivity and pricing actions. The heavier reliance on price increases and a mix shift away from higher-margin items not only compressed margins but also hurt volumes, underscoring the delicate balance between protecting profitability and sustaining demand.

Higher Interest Expense and Persistent Leverage Burden

Funding costs are rising, with interest expense up 17% year-over-year to $14 million due to higher spreads and amortization of deferred financing fees, which further eats into earnings power. While net debt has been reduced, the company’s leverage remains significant at $505 million and 4.3 times, and management is actively working through options to address a key debt maturity while it continues its broader strategic review.

Strategic Review Adds Uncertainty to Outlook

The ongoing strategic review, including potential additional asset sales and refinancing decisions, is a central theme and a key source of uncertainty for investors trying to model the company’s future. Management expressed confidence in the long-term benefits of its restructuring and portfolio shifts, but acknowledged that the timing and outcomes of strategic actions could affect execution risk and capital structure decisions over the coming quarters.

Directionally Positive Guidance Without Hard Numbers

For forward-looking guidance, Hain Celestial avoided issuing numeric targets for fiscal 2026 due to the strategic review, but leaned on directional metrics that point to improving profitability and cash discipline. Management is targeting go-forward North America gross margins above 30% and low-double-digit EBITDA margins, expects continued benefits from restructuring and stranded cost reductions through 2027, and plans to sustain positive free cash flow and leverage reduction while moderating capex and keeping over 70% of interest exposure hedged.

The overall message from Hain Celestial’s earnings call is that the company is making tangible progress on cash generation, deleveraging and margin repair, particularly in its refocused North American business, but still faces meaningful top-line and profitability challenges. Investors will be watching closely to see whether the current innovation pipeline, cost actions and portfolio reshaping can overcome international weakness, category headwinds and higher interest costs, and how the ongoing strategic review ultimately reshapes the company’s trajectory.